"Phospholipid Ethers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.
| Descriptor ID |
D010742
|
| MeSH Number(s) |
D02.033.800.875.875.750 D02.355.460.750 D10.570.755.375.760.400.985
|
| Concept/Terms |
Phospholipid Ethers- Phospholipid Ethers
- Ethers, Phospholipid
- Glycerophosphate Ethers
- Ethers, Glycerophosphate
- Glycerol Phosphate Ethers
- Ethers, Glycerol Phosphate
- Phosphate Ethers, Glycerol
- Ether Phosphatidates
- Phosphatidates, Ether
- Ether Phospholipids
- Phospholipids, Ether
|
Below are MeSH descriptors whose meaning is more general than "Phospholipid Ethers".
Below are MeSH descriptors whose meaning is more specific than "Phospholipid Ethers".
This graph shows the total number of publications written about "Phospholipid Ethers" by people in this website by year, and whether "Phospholipid Ethers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 4 | 0 | 4 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phospholipid Ethers" by people in Profiles.
-
Naranjo AN, McNeely PM, Katsaras J, Robinson AS. Impact of purification conditions and history on A2A adenosine receptor activity: The role of CHAPS and lipids. Protein Expr Purif. 2016 08; 124:62-7.
-
Berger AC, Hanson PK, Wylie Nichols J, Corbett AH. A yeast model system for functional analysis of the Niemann-Pick type C protein 1 homolog, Ncr1p. Traffic. 2005 Oct; 6(10):907-17.
-
Pan YH, Yu BZ, Berg OG, Jain MK, Bahnson BJ. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive. Biochemistry. 2002 Dec 17; 41(50):14790-800.
-
Pushkareva MY, Wannberg SL, Janoff AS, Mayhew E. Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Cancer Immunol Immunother. 2000 Jan; 48(10):569-78.
-
Cuvillier O, Mayhew E, Janoff AS, Spiegel S. Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood. 1999 Nov 15; 94(10):3583-92.
-
Spiegel S, Olah Z, Cuvillier O, Edsall LC, Janoff AS. Differential effects of free and liposome-associated 1-O-octadecyl-2-O-methylglycerophosphocholine on protein kinase C. FEBS Lett. 1999 Jul 02; 454(1-2):137-41.
-
Pushkareva MY, Janoff AS, Mayhew E. Inhibition of cell division but not nuclear division by 1-O- octadecyl-2-O-methyl-Sn-glycero-3-phosphocholine. Cell Biol Int. 1999; 23(12):817-28.
-
Mayhew E, Ahmad I, Bhatia S, Dause R, Filep J, Janoff AS, Kaisheva E, Perkins WR, Zha Y, Franklin JC. Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent. Biochim Biophys Acta. 1997 Oct 02; 1329(1):139-48.
-
Peters AC, Ahmad I, Janoff AS, Pushkareva MY, Mayhew E. Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Lipids. 1997 Oct; 32(10):1045-54.
-
Perkins WR, Dause RB, Li X, Franklin JC, Cabral-Lilly DJ, Zha Y, Dank EH, Mayhew E, Janoff AS. Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity. Biochim Biophys Acta. 1997 Jul 05; 1327(1):61-8.